deltatrials
Completed PHASE1/PHASE2 NCT00618839

StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects

Open-Label, Controlled, Randomized, Comparative, Dose Escalation Study Of The Safety, Human Immunology, And Efficacy Of StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects In Patients Undergoing Sequential Skin Reconstruction Procedures

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Conditions Burns Degloving Injury Third Degree Burn Wound Infection
Interventions Cadaver allograft StrataGraft Skin Tissue
Updated 10 times since 2017 Last updated: Oct 11, 2019 Started: Jul 31, 2006 Primary completion: Apr 30, 2008 Completion: Apr 30, 2008

Listed as NCT00618839, this PHASE1/PHASE2 trial focuses on Burns and Degloving Injury and remains completed. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), it has been updated 10 times since 2006, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE1_PHASE2

▶ Show 5 earlier versions

  1. Nov 2019 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  2. Feb 2019 — Nov 2019 [monthly]

    Completed PHASE1_PHASE2

  3. Jun 2018 — Feb 2019 [monthly]

    Completed PHASE1_PHASE2

  4. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • Stratatech, a Mallinckrodt Company
Data source: Mallinckrodt

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Madison, United States
  • • Phoenix, United States